SCHEMBL22155604

SCHEMBL22155604

c1ccc(-c2ccc3ccc4ccc(-c5ccc6c(c5)c5ccccc5c5cc7c(cc65)oc5ccccc57)c5ccc2c3c45)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.39
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 4/20 0.38
MAPT P10636 4/20 0.38
HPGD P15428 4/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
RAB9A P51151 3/20 0.36
MAOB P27338 1/20 0.36
MAOA P21397 1/20 0.36
NPC1 O15118 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
PLA2G2A P14555 2/20 0.35
PLA2G4A P47712 2/20 0.35
ALOX5 P09917 1/20 0.35
CYP1A2 P05177 1/20 0.34
HCRTR1 O43613 1/20 0.34
PTGER4 P35408 1/20 0.34
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22255985 0.99 AHR (0.38) AHRKDM4EALDH1A1MAPTHPGD
SCHEMBL22256100 0.95 ALDH1A1 (0.35) AHRKDM4EALDH1A1MAPTHPGD
SCHEMBL22255942 0.94 PLA2G2A (0.39) AHRKDM4EALDH1A1MAPTHPGD
SCHEMBL22255959 0.94 AHR (0.39) AHRKDM4EALDH1A1MAPTHPGD
SCHEMBL27013229 0.92 KDM4E (0.42) AHRKDM4EALDH1A1MAPTHPGD
SCHEMBL27013225 0.92 KDM4E (0.42) AHRKDM4EALDH1A1MAPTHPGD
SCHEMBL22255999 0.92 AHR (0.35) AHRKDM4EALDH1A1MAPTHPGD
SCHEMBL27127661 0.91 AHR (0.40) AHRKDM4EALDH1A1MAPTHPGD
SCHEMBL27127642 0.91 AHR (0.41) AHRKDM4EALDH1A1MAPTHPGD
SCHEMBL12380088 0.90 AHR (0.44) AHRKDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11296282-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-04-05 US disclosed
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11296282-B2 Organic compound and organic electroluminescence device using the same SLCO4C1, EML4, SLCO2A1 AHR 2487/4885KDM4E 2771/4885ALDH1A1 386/4885
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME SLCO4C1, EML4, SLCO2A1 AHR 2487/4885KDM4E 2771/4885ALDH1A1 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.